Regulators OK Agilent buy of Stratagene

Date Posted: Monday, May 14, 2007

Print Email to a friend

Federal antitrust regulators said Thursday (10 may) they approved Agilent Technologies Inc.'s $246.2 million purchase of Stratagene Corp., which makes life science research and testing products.

According to a Federal Trade Commission notice, the government has completed its investigation of the deal and ended a waiting period on the cash transaction.

Santa Clara, Calif.-based Agilent, which makes measurement and testing devices for the electronics, communications, and life sciences industries, said April 6 that it would buy the La Jolla, Calif.-based Stratagene.

Shares of Agilent dropped 66 cents to $36.78 in morning trading Thursday, while shares of Stratagene rose 8 cents to $10.85.

Further Information: http://www.agilent.com

Related news from our archive

Agilent Signs Agreement to Acquire Stratagene
The acquisition of the life science research and diagnostic products provider is expected to broaden the customer base for both Agilent and Stratagene.